ABX 产品目录
ABX
先进的生化化合物制造和开发核医学化学品
- 的PET前体和FDG试剂盒供应商
- 生产和开发PET和SPECT前体和参考标准
- 制造试剂盒和盒，特别是用于FDG，F-DOPA，FLT，F-胆碱，NaF，F-Miso，FES和FET生产的试剂盒
- 用于甘露糖三乙酸酯的美国和欧洲药物主文件（DMF）（FDG前体）
- 用于试剂盒，PET和SPECT前体的其他DMF和技术文件
- 根据API的GMP定制合成和制造
- 设计，定制合成和生产 多肽 （根据要求提供GMP质量）
- 新： 用于68 Ga发电机的 HCl
- 稳定性研究的表现
- 新药包和盒式磁带的研发和与制药公司合作的热门实验室
- 开发放射性示踪剂和标记以及纯化策略
- ROVER – ABX PET评估软件
- 18 O-Water FDG等级和GMP等级的分销商
- 190名专业人士（其中25人拥有博士学位）
- 在制药条件下洁净室生产和填充
- 由
德国制药部门
– 美国食品和药物管理局（FDA）审核并接受为GMP API制造商 - 通过ISO 13485认证
|
Product |
CAS No. |
ABX |
|
Mannose Triflate, ultra pure |
[92051-23-5] |
100 |
|
Mannose Triflate, ultra pure |
[92051-23-5] |
101 |
|
Mannose Triflate, ultra pure |
[92051-23-5] |
102 |
|
Mannose Triflate PLUS, ultra pure |
[92051-23-5] |
105 |
|
Mannose Triflate PLUS, ultra pure |
[92051-23-5] |
107 |
|
FDG |
[86783-82-6] (cyclic form) |
1100 |
|
6-Deoxy-6-fluoro-D-glucopyranose |
[34168-77-9] pyranoside |
1108 |
|
6-FDG precursor |
[899808-81-2] |
1109 |
|
ClDG |
[14685-79-1] |
1110 |
|
Glucose Triflate |
[113544-40-4] |
1117 |
|
MBETG |
CAS-RN not yet assigned |
1118 |
|
MBBTG |
[107794-71-8] |
1119 |
|
FDM |
[31077-88-0] |
1120 |
|
ACY-FDG |
[31077-89-1] |
1130 |
|
1,2,3,4-Tetra-O-acetyl-beta-D-glucopyranose |
[13100-46-4] |
1131 |
|
Me-4-FDG precursor |
[174618-11-2] |
1138 |
|
Talose Triflate |
CAS-RN not yet assigned |
1140 |
|
FDGal |
[7226-39-3] |
1150 |
|
DMTr-lyxothymidine |
[112501-53-8] |
1180 |
|
DMTr-Nosyl-lyxothymidine |
[444717-20-8] |
1190 |
|
Dimethoxybenzyl-FLT precursor |
[290371-75-4] |
1200 |
|
Anhydrothymidine-FLT precursor |
[191474-13-2] |
1210 |
|
FLT Ultra Pure |
[25526-93-6] |
1219 |
|
3′-Fluoro-thymidine (FLT) |
[25526-93-6] |
1220 |
|
3′-Iodo-thymidine |
[14260-82-3] |
1222 |
|
5′-O-Benzoyl-2,3′-anhydrothymidine |
[70838-44-7] |
1230 |
|
5′-O-Benzoyl-2,3′-anhydrothymidine (GMP) |
[70838-44-7] |
1231 |
|
3-N-Boc-5′-O-dimethoxytrityl-3′-O-nosyl-thymidine |
[444717-23-1] |
1240 |
|
3-N-Boc-5′-O-dimethoxytrityl-3′-O-nosyl-thymidine (GMP) |
[444717-23-1] |
1241 |
|
2,2′-Anhydrothymidine |
[22423-26-3] |
1250 |
|
2′-Fluoro-thymidine |
[122799-38-6] |
1260 |
|
3-N-Boc-5′-O-dimethoxytrityl-3′-fluorothymidine |
[138685-99-1] |
1261 |
|
DEMM |
[93504-92-8] |
1280 |
|
Thymidine |
[50-89-5] |
1290 |
|
6-Trimethylstannyl-L-DOPA |
[143993-90-2] |
1300 |
|
6-Trimethylstannyl-D,L-DOPA |
CAS-RN not yet assigned |
1302 |
|
6-Trimethylstannyl-D-DOPA |
CAS-RN not yet assigned |
1303 |
|
6-Fluoro-L-DOPA hydrochloride |
[144334-59-8] |
1310 |
|
6-Fluoro-D,L-DOPA hydrochloride |
[102034-49-1] (free base) |
1311 |
|
F-L-DOPA pinacol boronate precursor |
CAS-RN not yet assigned |
1312 |
|
DiBoc-Iodo-L-DOPA |
[143993-89-9] |
1320 |
|
3,4-Di-O-Pivaloyl-L-DOPA |
[42567-91-9] |
1328 |
|
4-O-Pivaloyl-L-DOPA Hydrochloride |
[122769-71-5] |
1329 |
|
4-O-Pivaloyl-L-DOPA |
[122551-95-5] |
1330 |
|
6-Hydroxy-D,L-DOPA |
[21373-30-8] |
1332 |
|
Nucleophilic F-L-DOPA precursor |
[1159940-23-4] |
1335 |
|
n.c.a. Nucleophilic F-L-DOPA precursor |
CAS-RN not yet assigned |
1336 |
|
6-Nitro-L-DOPA hydrogensulfate |
[1261156-59-5] (free base) |
1337 |
|
6-Nitro-Formyl-DOPA HCl |
CAS-RN not yet assigned |
1338 |
|
6-Fluoro-Formyl-DOPA HCl |
CAS-RN not yet assigned |
1339 |
|
TriBoc-L-DOPA methyl ester |
[857502-21-7] |
1340 |
|
TriBoc-D,L-DOPA ethyl ester |
CAS-RN not yet assigned |
1341 |
|
TriBoc-L-DOPA ethyl ester |
[203398-46-3] |
1342 |
|
TriBoc-Iodo-L-DOPA |
[853759-55-4] |
1350 |
|
OMFD precursor ABX004 |
CAS-RN not yet assigned |
1363 |
|
OMFD |
[114077-01-9] |
1369 |
|
N-Trifluoroacetyl-3,4-dimethoxy-6-trimethylstannyl-phenethylamine |
[170465-14-2] |
1370 |
|
N-Trifluoroacetyl-3,4-di-tert-butoxycarbonyloxy-6-trimethylstannyl-phenethylamine |
[170953-68-1] |
1371 |
|
6-Fluorodopamine |
[71144-39-3] |
1380 |
|
NITTP |
[150196-34-2] |
1400 |
|
NITTP (GMP) |
[150196-34-2] |
1401 |
|
NITTP (GMP) |
[150196-34-2] |
1402 |
|
Fluoromisonidazole |
[13551-89-8] |
1410 |
|
Desmethylmisonidazole |
[13551-92-3] |
1420 |
|
FETNIM precursor |
[163714-99-6] |
1430 |
|
FETNIM |
[204977-05-9]([18F]FETNIM) |
1440 |
|
1-(2,3-Diacetyl-5-tosyl-(α-D-arabinofuranosyl)-2-nitroimidazole |
[494775-35-8] |
1450 |
|
1-(5-Deoxy-5-fluoro-α-D-arabinofuranosyl)-2-nitroimidazole |
[220793-03-3] |
1451 |
|
N-(2-Tosyloxyethyl)phthalimide |
[5460-83-3] |
1452 |
|
2,3,5,6-Tetrafluorophenyl-2-(2-nitroimidazol-1-yl)acetate |
[199734-70-8] |
1453 |
|
N-(2-Fluoroethyl)-2-(2-nitroimidazol-1-yl)acetamide |
[199800-19-6] |
1454 |
|
ATSM |
[63618-91-7] |
1455 |
|
PTSM |
[673-68-7] |
1456 |
|
CuATSM |
[68341-09-3] |
1457 |
|
NiATSM |
[30193-04-5] |
1459 |
|
(R)-SCH-24518 hydrochloride |
[128145-75-5] |
1460 |
|
(S)-SCH-24518 hydrochloride |
[1217462-17-3] |
1462 |
|
SCH-23390 hydrochloride |
[125941-87-9] |
1464 |
|
SCH-23388 hydrochloride |
[1217443-99-6] |
1466 |
|
(R)-(-)-Norapomorphine hydrobromide |
[115017-61-3] |
1477 |
|
(+)-Desmethyl-NNC112 |
[221132-62-3] |
1480 |
|
(+)-NNC112 |
[125341-24-4] |
1490 |
|
(S)-O-Desmethylraclopride hydrobromide |
[113310-88-6] |
1500 |
|
(R)-O-Desmethylraclopride hydrobromide |
[113310-87-5] |
1501 |
|
(R,S)-O-Desmethylraclopride hydrobromide |
[857335-91-2] (free base) |
1502 |
|
(S)-O-Desmethylraclopride |
[119670-11-0] |
1510 |
|
Raclopride |
[84225-95-6] |
1520 |
|
Tin-epidepride precursor |
[135382-47-7] |
1521 |
|
Epidepride |
[107188-87-4] |
1522 |
|
FLB 604 |
[128600-22-6] |
1530 |
|
FLB 457 |
[107188-74-9] |
1540 |
|
Tosyl-Fallypride |
[166173-74-6] |
1550 |
|
Fallypride |
[166173-78-0] |
1560 |
|
Tosyl-Desmethoxyfallypride |
[713135-14-9] |
1570 |
|
Desmethoxyfallypride |
[166173-81-5] |
1580 |
|
N-Mesitylenesulfonyloxy-ethyl-spiperone |
[128584-73-6] |
1590 |
|
Fluoroethylspiperone |
[106114-42-5] |
1591 |
|
D-threo-N-NPS-Ritalinic acid |
[159701-28-7] |
1592 |
|
D-threo-Methylphenidate hydrochloride |
[19262-68-1] |
1593 |
|
(R)-N-Desmethyl PK11195 |
[157809-85-3] |
1600 |
|
(S)-PK 11195 |
[205934-45-8] |
1609 |
|
(R)-PK11195 |
[205934-46-9] |
1610 |
|
(R,S)-PK11195 |
[85532-75-8] |
1611 |
|
(S)-N-Desmethyl PK11195 |
[157809-86-4] |
1620 |
|
(R,S)-N-Desmethyl PK11195 |
[124236-61-9] |
1640 |
|
(+)-9-MeO-HNO hydrochloride |
[99833-85-9] |
1642 |
|
(+)-HNO hydrochloride |
[858517-21-2] |
1643 |
|
(+)-PHNO hydrochloride |
[99705-65-4] |
1645 |
|
(+)-F-PHNO |
[905963-70-4] |
1646 |
|
(+)-HNO hydrochloride (GMP) |
[858517-21-2] |
1647 |
|
PBR28 precursor |
[1005325-42-7] |
1652 |
|
PBR28 standard |
[253307-72-1] |
1653 |
|
FEPPA precursor |
[1095267-89-2] |
1654 |
|
FEPPA standard |
[1095267-90-5] |
1655 |
|
Azidomazenil |
[91917-65-6] |
1680 |
|
Desmethylazidomazenil |
[143188-51-6] |
1681 |
|
Nitromazenil |
[84377-97-9] |
1690 |
|
Mazenil pinacol boronate |
CAS-RN not yet assigned |
1691 |
|
Desmethylflumazenil |
[79089-72-8] |
1700 |
|
Flumazenil |
[78755-81-4] |
1710 |
|
Flumazenil acid |
[84378-44-9] |
1720 |
|
Tosyloxyethylflumazenil |
[676437-17-5] |
1721 |
|
Fluoroethylflumazenil |
[676437-19-7] ([18F]FFMZ) |
1730 |
|
Harmol |
[487-03-6] |
1753 |
|
Harmine |
[442-51-3] |
1755 |
|
(R)-Metomidate hydrochloride |
[66392-64-1] |
1760 |
|
(S)-Metomidate hydrochloride |
[66392-65-2] |
1762 |
|
(R)-Etomidate |
[33125-97-2] |
1770 |
|
(R)-Desethyl-Etomidate |
[56649-48-0] |
1780 |
|
(S)-Desethyl-Etomidate |
[56649-49-1] |
1782 |
|
(R)-Fluoroethyl-Etomidate |
[960403-07-0] |
1790 |
|
Nitro-Altanserin |
[139418-53-4] |
1800 |
|
Altanserin |
[76330-71-7] |
1810 |
|
Nitro-Setoperone |
[113981-16-1] |
1820 |
|
Setoperone |
[86487-64-1] |
1830 |
|
MDL105725 |
[189192-18-5] |
1840 |
|
MDL100907 |
[139290-65-6] |
1850 |
|
MDL100151 |
[139290-69-0] |
1860 |
|
MDL100907 tartrate salt |
[139290-65-6] (free base) |
1870 |
|
SB206453 |
[148702-73-2] |
1880 |
|
SB206453 (GMP) |
[148702-73-2] |
1881 |
|
SB207145 |
[148702-79-8] |
1882 |
|
MMSE |
[177714-21-5] |
1900 |
|
16α-Fluoroestradiol |
[92817-10-2] |
1910 |
|
FDHT precursor |
[141664-05-3] |
1916 |
|
FDHT standard |
[141663-88-9] |
1918 |
|
TNB-Androstanone |
CAS-RN not yet assigned |
1919 |
|
FFNP precursor |
[445379-33-9] |
1926 |
|
FFNP standard |
[160388-33-0] |
1928 |
|
3-O-Trityl-6-O-desmethyl-diprenorphine |
[157891-92-4] |
2000 |
|
Diprenorphine hydrochloride |
[16808-86-9] |
2010 |
|
Diprenorphine |
[14357-78-9] |
2020 |
|
3-O-Trityl-diprenorphine |
[157891-91-3] |
2030 |
|
6-O-Fluoroethyl-6-O-desmethyl-diprenorphine |
CAS-RN not yet assigned |
2040 |
|
6-O-Fluoroethyl-6-O-desmethyl-3-O-trityl-diprenorphine |
CAS-RN not yet assigned |
2050 |
|
3-O-Trityl-6-O-desmethyl-phenethyl-orvinol |
[1187551-69-4] |
2051 |
|
Phenethyl-orvinol |
[14521-98-3 |
2052 |
|
6-O-(2-Fluoroethyl)-6-O-desmethyl-phenethyl-orvinol |
CAS-RN not yet assigned |
2053 |
|
3-O-Trityl-6-O-desmethyl-buprenorphine |
[157891-93-5] |
2055 |
|
Buprenorphine hydrochloride |
[53152-21-9] |
2056 |
|
(S)-(-)-Normethylcarbamoyl-GR 103545 |
[260992-21-0] |
2060 |
|
(R)-(+)-Normethylcarbamoyl-GR 103545 |
[199470-02-5] |
2061 |
|
Normethylcarbamoyl-GR 89696 |
[126766-48-1] |
2062 |
|
GR 89696 fumarate |
[126766-32-3] |
2070 |
|
(R)-(-)-GR103545 fumarate |
[126766-43-6] |
2071 |
|
(S)-(+)-GR89696 fumarate |
[150133-21-4] |
2072 |
|
Acetic acid piperidin-4-yl ester hydrochloride |
[94886-04-1] |
2110 |
|
Acetic acid 1-methyl-piperidin-4-yl ester hydrochloride |
[58931-63-8] |
2120 |
|
Propionic acid piperidin-4-yl ester hydrochloride |
[219859-83-3] |
2130 |
|
Propionic acid 1-methyl-piperidin-4-yl ester hydrochloride |
[64219-77-8] |
2140 |
|
Butyric acid piperidin-4-yl ester hydrochloride |
CAS-RN not yet assigned |
2150 |
|
Butyric acid 1-methyl-piperidin-4-yl ester hydrochloride |
CAS-RN not yet assigned |
2160 |
|
L-Homocysteine |
[6027-13-0] |
2200 |
|
D,L-Homocysteine |
[454-29-5] |
2205 |
|
L-Homocysteine thiolactone hydrochloride |
[31828-68-9] |
2210 |
|
L-Methionine |
[63-68-3] |
2220 |
|
D-Methionine |
[348-67-4] |
2229 |
|
D,L-Methionine |
[59-51-8] |
2230 |
|
N-Boc-trans-4-tosyloxy-L-proline methyl ester |
[88043-21-4] |
2300 |
|
N-Boc-trans-4-mesyloxy-D-proline tert-butyl ester |
CAS-RN not yet assigned |
2301 |
|
N-Boc-cis-4-tosyloxy-L-proline methyl ester |
CAS-RN not yet assigned |
2310 |
|
cis-4-Fluoro-L-proline |
[2438-57-5] |
2320 |
|
cis-4-Fluoro-D-proline hydrochloride |
[913820-71-0] (free amino acid) |
2321 |
|
trans-4-Fluoro-L-proline |
[2507-61-1] |
2330 |
|
rac [11C]-AIB precursor |
[115134-32-2] (S-AIB-precursor) |
2340 |
|
S-[11C]-AIB precursor |
[115134-32-2] |
2342 |
|
Desmethylcar* acid |
[186022-53-7] |
2390 |
|
Desmethylcar*, sodium salt |
[98598-82-4] |
2400 |
|
Fluoroethyl-Car* |
[904892-57-5] |
2420 |
|
Fluoroethyl-Car* hydrochloride |
[1007840-96-1] |
2421 |
|
(S)-FPSPPA |
[1283095-64-6] |
2450 |
|
(R)-FPSPPA |
[1283095-67-9] |
2460 |
|
(S)-Methyl-FPSPPA |
[1283095-70-4] |
2470 |
|
(R)-Methyl-FPSPPA |
[1283095-73-7] |
2480 |
|
(R)-Desisopropylcarazolol |
[143412-41-3] |
2500 |
|
(S)-Desisopropylcarazolol |
[143412-40-2] |
2510 |
|
(R,S)-Desisopropylcarazolol |
[72955-96-5] |
2511 |
|
(R)-Carazolol |
[78859-34-4] |
2520 |
|
(S)-Carazolol |
[78859-33-3] |
2530 |
|
(R,S)-Carazolol |
[57775-29-8] |
2540 |
|
(S)-N-Desisopropylpropranolol |
[88547-38-0] |
2550 |
|
GB 99 |
[116784-78-2] |
2570 |
|
GB 67 |
[116784-70-4] |
2580 |
|
(S)-1-(2-Amino-3-nitrophenoxy)-3-tert-butylamino-propan-2-ol |
[132059-12-2] |
2590 |
|
4-(2-Keto-3-methyl-1-benzimidazolinyl)piperidine |
[53786-10-0] |
2700 |
|
Cyclopropyl-p-nitrophenyl ketone |
[93639-12-4] |
2750 |
|
FNMB |
[133066-70-3] |
2760 |
|
3-O-Benzyl-naltrindole |
[161532-22-5] |
2800 |
|
N-Methylnaltrindole |
[111555-57-8] |
2810 |
|
QNB |
[6581-06-2] |
2830 |
|
Me-QNB |
[71861-83-1] |
2840 |
|
Benzyl-14-(R,S)-tosyloxy-6-thiaheptadecanoate |
[137564-70-6] |
2850 |
|
14-(R,S)-Fluoro-6-thiaheptadecanoic acid |
[137564-72-8] |
2860 |
|
2-O-(Trifluoromethylsulfonyl)-1,3,5-tri-O-benzoyl-α-L-ribofuranose |
[339091-18-8] |
2869 |
|
2-O-(Trifluoromethylsulfonyl)-1,3,5-tri-O-benzoyl-α-D-ribofuranose |
[97614-41-0] |
2870 |
|
5-Ethyl-2,4-bis[(trimethylsilyl)oxy]pyrimidine |
[31167-05-2] |
2871 |
|
5-Methyl-2,4-bis[(trimethylsilyl)oxy]pyrimidine |
[7288-28-0] |
2872 |
|
Bis(trimethylsilyl)cytosine |
[18037-10-0] |
2873 |
|
L-FEAU |
[171720-95-9] |
2874 |
|
α-L-FEAU |
CAS-RN not yet assigned |
2875 |
|
FEAU |
[83546-42-3] |
2876 |
|
αFEAU |
CAS-RN not yet assigned |
2877 |
|
FMAU |
[69256-17-3] |
2878 |
|
αFMAU |
[97672-34-9] |
2879 |
|
FTRU |
[336881-26-6] |
2880 |
|
FTAU |
[213136-14-2] |
2890 |
|
FAU |
[69123-94-0] |
2900 |
|
FIAU |
[69123-98-4] |
2910 |
|
FUdR |
[784-71-4] |
2920 |
|
Di-THP-nosyl-AUR |
[1000816-92-1] |
2921 |
|
FIRU |
[55612-21-0] |
2922 |
|
FAC |
[56632-83-8] |
2930 |
|
αFAC |
CAS-RN not yet assigned |
2931 |
|
3′-Fluoro-2′,3′-dideoxyuridine |
[41107-56-6] |
2940 |
|
5-Trimethylstannyl-2′-deoxyuridine |
[146629-34-7] |
2948 |
|
IUdR |
[54-42-2] |
2949 |
|
2′-Deoxy-L-uridine |
[31501-19-6] |
2950 |
|
Nitro-Xeloda |
[865474-03-9] |
2952 |
|
Xeloda |
[154361-50-9] |
2953 |
|
2′,3′-Didehydro-3′-deoxythymidine |
[3056-17-5] |
2954 |
|
5-Fluorouracil precursor |
[219638-33-2] (cation) |
2958 |
|
Tosyl-FHBG |
[206067-84-7] |
2960 |
|
FHBG |
[206067-83-6] |
2970 |
|
N,O-Di-Boc-2-TMSn-L-tyrosine ethyl ester |
[400885-40-7] |
3000 |
|
2-Fluoro-tyrosine |
[78709-81-6] |
3010 |
|
2-Iodo-tyrosine |
[78853-38-0] |
3020 |
|
Thyronamine Hydrochloride |
[5221-18-1] |
3035 |
|
3-Iodothyronamine Hydrochloride |
[788824-64-6] |
3036 |
|
TET |
[478037-15-9] |
3050 |
|
TET (GMP) |
[478037-15-9] |
3051 |
|
TET (GMP) |
[478037-15-9] |
3052 |
|
FET hydrochloride |
[854750-33-7] (free base) |
3061 |
|
D-FET hydrochloride |
[223463-90-9] (free base) |
3071 |
|
(L)-HET hydrochloride |
[481052-68-0] (free base) |
3081 |
|
N-Trifluoroacetyl-5-acetoxy-2-trimethylstannyl-phenylalanine ethyl ester |
[148613-10-9] |
3100 |
|
N,O-Di-Boc-2-TMSn-m-tyrosine ethyl ester |
[845882-24-8] |
3110 |
|
2-Fluoro-m-Tyrosine |
[148613-12-1] |
3130 |
|
2-Iodo-α-methyl-p-tyrosine |
CAS-RN not yet assigned |
3180 |
|
3-Iodo-α-methyl-p-tyrosine |
[4298-17-3] |
3190 |
|
(S)-tert-Butyl 2-((tert-butoxycarbonyl) amino)-4-Iodobutanoat |
[161370-66-7] |
3191 |
|
WAY 100634 |
[155204-28-7] |
3200 |
|
WAY 100635 |
[146714-97-8] |
3210 |
|
Desmethyl-WAY100635 |
[146715-34-6] |
3220 |
|
Desmethyl-WAY 100634 |
[146714-76-3] |
3230 |
|
Nitro-MPPF |
[155204-27-6] |
3240 |
|
MPPF |
[155204-26-5] |
3250 |
|
Desmethyl-MPT |
[874471-23-5] |
3260 |
|
MPT |
[179756-59-3] |
3270 |
|
TAP |
[213766-21-3] |
3300 |
|
IAP |
[213764-92-2] |
3310 |
|
Nitro-AP |
[209530-92-7] |
3320 |
|
FAP tartrate |
[209530-93-8] (free base) |
3340 |
|
TMA-AP |
[233766-75-1] |
3350 |
|
(-)-Flubatine standard |
[845642-53-7] |
3351 |
|
(-)-Flubatine precursor |
[1421915-93-6] |
3353 |
|
(-)-Flubatine precursor (GMP) |
[1421915-93-6] |
3354 |
|
(+)-Flubatine standard |
[845642-52-6] |
3355 |
|
(+)-Flubatine precursor |
CAS-RN not yet assigned |
3357 |
|
(+)-Flubatine precursor (GMP) |
CAS-RN not yet assigned |
3358 |
|
ASEM precursor |
[1456877-71-6] |
3371 |
|
Metaraminol (free base) |
[54-49-9] |
3380 |
|
Metaraminol bitartrate |
[33402-03-8] |
3390 |
|
MHED hydrochloride |
[24493-89-8] |
3400 |
|
Desmethyl-GR 205171 |
[180574-25-8] |
3500 |
|
GR 205171 |
[168266-90-8] |
3510 |
|
Desmethyl-GR 205171 Dihydrochloride |
[262598-97-0] |
3520 |
|
GR 205171 Dihydrochloride |
[168266-51-1] |
3530 |
|
Desmethyl-CNS 5161 |
[160754-78-9] |
3540 |
|
CNS 5161 |
[160754-76-7] |
3550 |
|
Desmethyl ABP688 |
[849469-03-0] |
3560 |
|
Desmethyl ABP688 (GMP) |
[849469-03-0] |
3561 |
|
ABP688 |
[924298-51-1] |
3570 |
|
FPEB precursor |
[1031370-96-3] |
3571 |
|
FPEB standard |
[864063-10-5] |
3572 |
|
ISOM |
[945992-43-8] |
3590 |
|
ISOF |
[851705-46-9] |
3591 |
|
Desmethyl-SCH-442416 |
[188112-92-7] |
3700 |
|
SCH-442416 |
[316173-57-6] |
3710 |
|
Desmethyl-MK-8278 |
[879368-41-9] |
3720 |
|
CPTPX |
[478173-67-0] |
3750 |
|
CPFPX |
[200557-18-2] |
3751 |
|
(-)-2-beta-Carbomethoxy-3-beta-(4-fluorophenyl)tropane |
[50370-56-4] |
4000 |
|
(-)-2-beta-Carbomethoxy-3-beta-(4-fluorophenyl)nortropane |
[127648-30-0] |
4020 |
|
(-)-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)tropane |
[135416-43-2] |
4030 |
|
TMS-CT |
[158111-10-5] |
4040 |
|
TBS-CT |
[136794-88-2] |
4041 |
|
(-)-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)nortropane |
[136794-87-1] |
4050 |
|
(-)-2-beta-Carbomethoxy-3-beta-(phenyl)tropane |
[50372-80-0] |
4060 |
|
CITFES |
[180045-77-6] |
4100 |
|
CITFE |
[155798-01-9] |
4110 |
|
CITTP Tosylate |
[186381-39-5] (free base) |
4122 |
|
CITFP |
[155797-99-2] |
4130 |
|
TBSCT-FP |
[479642-48-3] |
4132 |
|
beta-CIT acid |
[141807-58-1] |
4140 |
|
2-FE-beta-CIT |
[398497-81-9] |
4150 |
|
PE2I acid |
[311351-26-5] |
4160 |
|
PE2I tin precursor |
[188680-65-1] |
4165 |
|
PE2I |
[188680-71-9] |
4170 |
|
TEO-PE2I |
[1391711-43-5] |
4172 |
|
FE-PE2I |
[949091-68-3] |
4173 |
|
Nor-beta-CClT |
[146725-33-9] |
4180 |
|
FECNT |
[281667-94-5] |
4190 |
|
Altropane acid |
[335104-67-1] |
4200 |
|
Altropane acid hydrochloride |
[335104-67-1] (Altropane acid free amine) |
4201 |
|
Altropane |
[180468-34-2] |
4210 |
|
Altropane hydrochloride |
[180468-34-2] (free base) |
4211 |
|
Norbenztropine |
[28404-87-7] |
4230 |
|
Benztropine Mesylate |
[132-17-2] |
4231 |
|
MASB |
[296774-10-2] |
4300 |
|
MASB (GMP) |
[296774-10-2] |
4301 |
|
DASB |
[627490-01-1] |
4310 |
|
DASB (GMP) |
[627490-01-1] |
4311 |
|
AFM precursor |
[844699-84-9] (free base) |
4320 |
|
AFM standard |
[627490-40-8] (free base) |
4330 |
|
(+)-McN 5652 Thiobutyrate |
[167548-65-4] (free base) |
4360 |
|
(+)-McN 5652 |
[259145-56-7] |
4370 |
|
(-)-McN 5652 |
[262352-33-0] |
4380 |
|
(+)-Fluoromethyl-McN 5652 |
[432038-21-6] (free base) |
4381 |
|
FBAM precursor |
[937025-28-0] |
4383 |
|
FBAM standard |
[937025-29-1] |
4384 |
|
CPTMA |
[124915-01-1] |
4385 |
|
CMTMA |
[51570-69-5] (CMTMA cation) |
4386 |
|
TBAB |
[660845-84-1] |
4389 |
|
PMBAB |
[223699-69-2] |
4390 |
|
FB precursor |
[124915-06-6] |
4391 |
|
SFB |
[66134-67-6] |
4392 |
|
[18F]FPyBrA/[18F]FPyME precursor |
[640749-64-0] |
4393 |
|
FPyME standard |
[640749-61-7] |
4394 |
|
[18F]FPyKYNE precursor |
[1161009-68-2] |
4396 |
|
FPyKYNE |
[1161009-63-7] |
4397 |
|
FBEM precursor |
[146474-00-2] |
4398 |
|
FBEM standard |
[1089194-09-1] |
4399 |
|
(2S,3S)-N-Boc-norethylreboxetine |
[754988-84-6] |
4400 |
|
(2S,3S)-N-Boc-carboxylreboxetine |
[1016545-04-2] |
4402 |
|
(2S,3S)-Carboxylreboxetine fluoroethyl ester trifluoroacetate |
CAS-RN not yet assigned |
4403 |
|
Methylreboxetinecarboxylate |
[1016545-13-3] (free base) |
4405 |
|
(2S,3S)-Methylreboxetine |
[105018-14-2] |
4406 |
|
(2S,3S)-Desethylreboxetine |
[252570-31-3] |
4407 |
|
Norbinaltorphimine dihydrochloride |
[113158-34-2] |
4500 |
|
(-)-TEBV |
[153215-71-5] |
4600 |
|
(-)-FEBV |
[153215-70-4] |
4610 |
|
(±)-9-O-Desmethyl-α-dihydrotetrabenazine |
[5220-98-4] |
4700 |
|
(+)-9-O-Desmethyl-α-dihydrotetrabenazine |
CAS-RN not yet assigned |
4710 |
|
(-)-9-O-Desmethyl-α-dihydrotetrabenazine |
CAS-RN not yet assigned |
4720 |
|
(±)-α-Dihydrotetrabenazine |
[3466-75-9] |
4730 |
|
(±)-beta-Dihydrotetrabenazine |
CAS-RN not yet assigned |
4731 |
|
(±)-Tetrabenazine |
[58-46-8] |
4732 |
|
(±)-9-O-Desmethyl-tetrabenazine |
[149183-89-1] |
4733 |
|
Aminothiadiazine |
[319002-53-4] |
4900 |
|
Chlorothiadiazine |
[194086-61-8] |
4910 |
|
DMTEAN |
[259739-02-1] |
5000 |
|
DFEAN |
[1161260-63-4] ([18F]DFEAN) |
5010 |
|
DMEAN |
[259739-01-0] |
5020 |
|
DMFEAN |
[590365-47-2] |
5030 |
|
6-OH-BTA-0 |
[178804-18-7] |
5100 |
|
6-OH-BTA-0 (GMP) |
[178804-18-7] |
5101 |
|
6-MOMO-BTA-0 |
[566170-03-4] |
5110 |
|
6-MOMO-BTA-0 (GMP) |
[566170-03-4] |
5111 |
|
6-OH-BTA-1 hydrochloride |
CAS-RN not yet assigned |
5120 |
|
6-MeO-BTA-0 |
[43036-17-5] |
5130 |
|
6-OH-BTA-1 (free base) |
[566169-93-5] |
5140 |
|
6-O-Tosyloxyethyl-CBT |
[1392498-16-6] |
5149 |
|
[18F]Lansoprazole Precursor |
[1613520-76-5] |
5150 |
|
Astemizole |
[68844-77-9] |
5165 |
|
O-Desmethyl Astemizole |
[73736-50-2] |
5166 |
|
Desmethyl-PD 153035 |
[295330-61-9] |
5200 |
|
PD 153035 |
[153436-54-5] |
5210 |
|
Norverapamil |
[67018-85-3] |
5600 |
|
(-)-Norverapamil |
[123931-31-7] |
5620 |
|
(+)-Verapamil hydrochloride |
[38176-02-2] |
5630 |
|
N-Demethylrifampicin |
[13292-45-0] |
5700 |
|
Rolipram |
[61413-54-5] |
6000 |
|
(S)-(+)-Rolipram |
[85416-73-5] |
6010 |
|
(R)-(-)-Rolipram |
[85416-75-7] |
6020 |
|
Desmethyl-Rolipram |
[150519-28-1] |
6030 |
|
(S)-(+)-Desmethyl-Rolipram |
[347148-60-1] |
6040 |
|
(R)-(-)-Desmethyl-Rolipram |
[347148-59-8] |
6050 |
|
Dimethylaminoethanol |
[108-01-0] |
6100 |
|
Fluoroethylcholine tosylate |
[479407-07-3] |
6120 |
|
Fluoromethylcholine chloride |
[459424-38-5] |
6130 |
|
Fluoromethylcholine bromide |
CAS-RN not yet assigned |
6140 |
|
Bromocholine bromide |
[28508-20-5] |
6141 |
|
Choline chloride |
[67-48-1] |
6150 |
|
Fluoroethylcholine chloride |
[479407-08-4] |
6160 |
|
Choline iodide |
[17773-10-3] |
6170 |
|
DMMB |
[40968-70-5] |
6173 |
|
BHTMEDA |
[60168-37-8] |
6174 |
|
Dibromoethane |
[106-93-4] |
6175 |
|
Dibromomethane |
[74-95-3] |
6176 |
|
Bis(tosyloxy)methane |
[24124-59-2] |
6177 |
|
1,2-Bis(nosyloxy)ethane |
[25297-82-9] |
6179 |
|
1,2-Bis(tosyloxy)ethane |
[6315-52-2] |
6180 |
|
2-Bromoethyl nosylate |
[52331-22-3] |
6181 |
|
2-Bromoethyl triflate |
[103935-47-3] |
6182 |
|
2-Bromoethyl tosylate |
[19263-21-9] |
6183 |
|
2-Fluoroethyl tosylate |
[383-50-6] |
6184 |
|
Bis(tosyl)-1,4-butanediol |
[4724-56-5] |
6185 |
|
1,4-Bis(tosyloxy)but-2-yne |
[6337-59-3] |
6186 |
|
3-Fluoropropyltosylate |
[312-68-5] |
6190 |
|
1,3-Propane-di-tosylate |
[5469-66-9] |
6191 |
|
Fluoromethyl tosylate |
[114435-86-8] |
6194 |
|
Ethyl (p-tosyloxy)acetate |
[39794-75-7] |
6200 |
|
Potassium fluoroacetate |
[23745-86-0] |
6210 |
|
Sodium fluoroacetate |
[62-74-8] |
6211 |
|
DBCO-SCN |
CAS-RN not yet assigned |
6221 |
|
1-Tosyloxy-3-butyne |
[23418-85-1] |
6301 |
|
1-Tosyloxy-4-pentyne |
[77758-50-0] |
6302 |
|
1-Tosyloxy-5-hexyne |
[76911-01-8] |
6303 |
|
Tosyl-propargyl-diethylene glycol |
[1119249-30-7] |
6305 |
|
Tosyl-propargyl-triethylene glycol |
[888009-94-7] |
6307 |
|
Fluoro-propargyl-triethylene glycol |
[1003005-81-9] ([18F]Fluoro-propargyl-triethylene glycol) |
6308 |
|
3-(4-Azidophenoxy)propyl methansulfonate |
[943726-04-3] |
6320 |
|
(S)-O-Tosyl-1,2-Epoxybutanol |
[91111-12-5] |
6351 |
|
Dimethyl-8-acetyl-hexahydropyrrolo[2,3]indol-1,2-dicarboxylate |
[79465-83-1] |
6500 |
|
α-Methyl-L-tryptophan |
[16709-25-4] |
6510 |
|
Dimethyl-8-phenylsulfonyl-5-phenylsulfonyloxy-hexahydropyrrolo[2,3]indol-1,2-dicarboxylate |
[150804-39-0] |
6520 |
|
5-FEHTP hydrochloride |
[1215091-03-4] (free base) |
6532 |
|
MIBG Hemisulfate |
[87862-25-7] |
7000 |
|
MIBG Hemisulfate (GMP) |
[87862-25-7] |
7001 |
|
MTMSBG |
[143773-92-6] (free base) |
7010 |
|
TMSnBG |
[1000875-21-7] |
7012 |
|
SGMIB Standard |
[344791-53-3] (free base) |
7014 |
|
SGMIB Precursor |
[344791-59-9] |
7015 |
|
CNS 1261 |
[341032-67-5] |
7020 |
|
TBS-CNS 1261 |
[765890-24-2] |
7030 |
|
MFBG pinacol boronate precursor |
CAS-RN not yet assigned |
7033 |
|
MFBG hydrochloride |
[1246547-53-4] |
7034 |
|
Mebrofenin |
[78266-06-5] |
7050 |
|
Disofenin |
[65717-97-7] |
7060 |
|
Succinimidyl-N-Boc-Hynic |
[133081-26-2] |
7080 |
|
Succinimidyl-Hynic hydrochloride |
[133081-27-3] |
7090 |
|
S-Benzoyl-MAG-3 |
[103725-47-9] |
7100 |
|
MAG 3 |
[66516-09-4] |
7110 |
|
(Benzoylmercapto)acetic acid |
[6398-74-9] |
7111 |
|
BMEDA |
[93798-62-0] |
7150 |
|
MDP |
[1984-15-2] |
7160 |
|
HMDP |
[14255-61-9] |
7161 |
|
EDTMP |
[1429-50-1] |
7165 |
|
MIBI |
[109434-22-2] |
7200 |
|
Copper tetraMIBI tetrafluoroborate [Cu(MIBI)4]BF4 |
[103694-84-4] |
7210 |
|
Copper tetraMIBI tetrafluoroborate (GMP) |
[103694-84-4] |
7211 |
|
Zinc-TBI |
[104676-71-3] |
7220 |
|
EC |
[14344-48-0] |
7250 |
|
ECD |
[14344-58-2] |
7260 |
|
TFP-N-sucDf-Fe |
[676596-40-0] |
7270 |
|
TACN |
[58966-93-1] |
7281 |
|
PrP9 |
[1242003-07-1] (water free compound) |
7284 |
|
Cyclen |
[294-90-6] |
7290 |
|
DOTA |
[60239-18-1] |
7300 |
|
DOTAEt |
[137076-50-7] |
7301 |
|
Tetrofosmin |
[127502-06-1] |
7310 |
|
Disodium sulfosalicylate |
[56343-01-2] |
7312 |
|
BPAMD |
[872469-60-8] |
7320 |
|
HBED-CC-tris(tBu)ester |
CAS-RN not yet assigned |
7330 |
|
HBED-CC-di(tBu)ester |
CAS-RN not yet assigned |
7331 |
|
TRODAT |
[189950-11-6] (free base) |
7400 |
|
S-(-)-BZM |
[84226-04-0] |
7500 |
|
S-(-)-IBZM |
[84226-06-2] |
7510 |
|
Gallium Citrate (complex) |
CAS-RN not yet assigned |
7520 |
|
16-Iodohexadecanoic acid |
[2536-36-9] |
7600 |
|
Cryptand 222 |
[23978-09-8] |
800 |
|
Lithium Aluminium Hydride in THF bulk |
[16853-85-3] |
801 |
|
Lithium aluminium hydride (0.1 M in THF) |
[16853-85-3] |
802 |
|
Lithium aluminium hydride (0.25 M in THF) |
[16853-85-3] |
803 |
|
Lithium aluminium hydride (0.05 M in THF) |
[16853-85-3] |
804 |
|
Tetrabutylammonium Hydrogen Carbonate (0.075 M) – Aqueous solution, stabilized with ethanol |
[17351-62-1] |
808 |
|
Pentadecylmagnesium bromide 0.5 M in diethyl ether |
[78887-70-4] |
831 |
|
Lithium aluminium hydride (0.1 M in THF) |
[16853-85-3] |
832 |
|
Fmoc-Lys(ivDde)-OH |
[204777-78-6] |
9500 |
|
PMPA |
[173039-10-6] |
9510 |
|
Ubiquicidin (29-41) acetate |
[216867-99-1] (net peptide) |
9600 |
|
DOTA-Ubiquicidin (29-41) acetate |
CAS-RN not yet assigned |
9601 |
|
Scrambled Ubiquicidin (29-41) |
CAS-RN not yet assigned |
9602 |
|
NOTA-Ubiquicidin (29-41) acetate |
CAS-RN not yet assigned |
9603 |
|
DOTATOC (GMP) |
[204318-14-9] |
9702 |
|
Ga-DOTA-TOC acetate |
[293295-70-2] |
9703 |
|
Y-DOTA-TOC |
[293295-66-6] |
9704 |
|
Lu-DOTA-TOC |
[321835-55-6] ([177Lu]-DOTA-TOC) |
9705 |
|
DOTA-NOC acetate |
[619300-53-7] (net peptide) |
9712 |
|
AMBA acetate |
[721937-56-0] (net peptide) |
9714 |
|
DOTA-[Pro1,Tyr4]bombesin (1-14) |
[593287-40-2] (net peptide) |
9715 |
|
DOTA-NOC acetate (GMP) |
[619300-53-7] (net peptide) |
9716 |
|
Ga-DOTA-NOC |
[1027785-95-0] |
9717 |
|
NODAGA-NOC acetate |
CAS-RN not yet assigned |
9718 |
|
HYNIC-TOC trifluoroacetate |
[257943-19-4] (net peptide) |
9721 |
|
HYNIC-NOC trifluoroacetate |
CAS-RN not yet assigned |
9730 |
|
Pentreotide trifluoroacetate |
[138661-02-6] (net peptide) |
9740 |
|
DTPA-TOC trifluoroacetate |
[147790-81-6] (net peptide) |
9744 |
|
Octreotide acetate |
[79517-01-4] |
9750 |
|
[Nal3]Octreotide acetate |
[848820-27-9] (net peptide) |
9752 |
|
TETA-Octreotide acetate |
[226084-96-4] (net peptide) |
9760 |
|
NOTA-Octreotide trifluoroacetate |
CAS-RN not yet assigned |
9762 |
|
NOTA-NOC acetate |
CAS-RN not yet assigned |
9765 |
|
Gluc-[Lys0,Lys(ivDde)5]-TOCA |
CAS-RN not yet assigned |
9771 |
|
DOTA-TATE acetate (GMP) |
[177943-89-4] |
9772 |
|
Ga-DOTA-TATE |
[777842-51-0] |
9773 |
|
[Tyr3]Octreotate acetate |
[302794-43-0] (net peptide) |
9774 |
|
Gluc-Lys(FP)-TOCA |
CAS-RN not yet assigned |
9778 |
|
ICG-TATE |
CAS-RN not yet assigned |
9782 |
|
Galacto-RGD |
[922175-70-0] (net peptide) |
9790 |
|
Fluoropropionyl-Galacto-RGD |
CAS-RN not yet assigned |
9800 |
|
NOTA-RGDfK acetate |
CAS-RN not yet assigned |
9802 |
|
Ga-NODAGA-RGD dimer |
CAS-RN not yet assigned |
9803 |
|
NODAGA-RGD dimer acetate |
CAS-RN not yet assigned |
9804 |
|
NODAGA-RGD trifluoroacetate |
CAS-RN not yet assigned |
9805 |
|
NODAGA-RGD (GMP) |
CAS-RN not yet assigned |
9806 |
|
Ga-NODAGA-RGD |
CAS-RN not yet assigned |
9807 |
|
[Tyr3]Octreotide acetate |
[103667-46-5] (net peptide) |
9810 |
|
NODAGA-AMBA trifluoroacetate |
CAS-RN not yet assigned |
9814 |
|
NOTA-AMBA trifluoroacetate |
CAS-RN not yet assigned |
9815 |
|
[Pro1,Tyr4]bombesin (1-14) |
[832724-21-7] (net peptide) |
9816 |
|
Lanreotide trifluoroacetate |
[108736-35-2] (net peptide) |
9820 |
|
DOTA-Lanreotide acetate |
[213187-44-1] (net peptide) |
9831 |
|
HYNIC-Lanreotide trifluoroacetate |
CAS-RN not yet assigned |
9836 |
|
4-Formyl-N,N,N-Trimethylanilinium triflate |
[124915-02-2] |
9850 |
|
DOTA-NAPamide trifluoroacetate |
[935886-72-9] (net peptide) |
9855 |
|
DOTA-Sargastrin |
CAS-RN not yet assigned |
9857 |
|
Cyclo-RGDfK |
[161552-03-0] |
9860 |
|
Cyclo-RGDfK dimer trifluoroacetate |
[250612-47-6] (net peptide) |
9861 |
|
DOTA-RGDfK dimer acetate |
[250612-06-7] (net peptide) |
9862 |
|
DOTA-cyclo(RGDfK) acetate |
[909024-55-1] (net peptide) |
9863 |
|
HYNIC-cyclo(RGDfK) trifluoroacetate |
[366455-78-9] (net peptide) |
9864 |
|
DTPA-Bn-cyclo(RDGfK) dimer trifluoroacetate |
[1004322-97-7] |
9866 |
|
HYNIC-cyclo(RGDfK) dimer trifluoroacetate |
[500166-11-0] |
9867 |
|
[Tyr3,Lys5(Boc)]octreotide acetate |
[147790-89-4] (net peptide) |
9900 |
|
[Lys5(Boc)]octreotate acetate |
[133304-78-6] (net peptide) |
9901 |
|
[Lys5(Boc)]lanreotide acetate |
[182482-12-8] (net peptide) |
9902 |
|
[Nal3,Lys5(Boc)]octreotide acetate |
CAS-RN not yet assigned |
9903 |
|
5(6)-FAM-TATE |
CAS-RN not yet assigned |
9908 |
|
PSMA-11 (GMP) |
[1366302-52-4] |
9919 |
|
PSMA-11 |
[1366302-52-4] |
9920 |
|
PSMA-11 (GMP) |
[1366302-52-4] |
9921 |
|
GaPSMA-11 |
CAS-RN not yet assigned |
9922 |
|
PSMA-10 |
CAS-RN not yet assigned |
9923 |
|
DCFPyL reference standard |
[1423758-00-2] |
9925 |
|
PSMA-617 |
CAS-RN not yet assigned |
9933 |
|
PSMA-617 (GMP) |
CAS-RN not yet assigned |
9934 |
|
GaPSMA-617 |
CAS-RN not yet assigned |
9935 |
|
LuPSMA-617 |
CAS-RN not yet assigned |
9936 |
|
deprotected DCFPyL precursor |
CAS-RN not yet assigned |
9941 |
|
PSMA-1007 precursor |
CAS-RN not yet assigned |
9943 |
|
PSMA-1007 reference standard |
CAS-RN not yet assigned |
99433 |
|
DOTA-Substance P |
CAS-RN not yet assigned |
9960 |
|
DOTA-Substance P |
CAS-RN not yet assigned |
9960 |
上海金畔生物科技有限公司是实验试剂一站式采购服务商
1：强大的进口辐射能力，血清、抗体、耗材、大部分限制进口品等。
2：产品种类齐全，经营超过700多品牌，基本涵盖所有生物实验试剂耗材。
3：提供加急服务，货品一般1-2周到货。
4：富有竞争力的价格优势，绝大部分价格有优势。
5：多年积累良好的信誉，大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校，ROCHE，阿斯利康、国药、fisher等知药企。
6：我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech；sysy,TriLink BioTechnologies,Inc；worthington-biochem,zyagen等几十家国外公司代理。
7：我们还是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等知*批发，欢迎合作。